Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Greenwich LifeSciences, Inc.
NASDAQ:GLSIHealthcare · Biotechnology
+6.83%$17.13
AH Close$17.01-0.67%vs close
AH Close$17.01-0.67%vs close
Mkt Cap$251.36M
Float6.34M
O/S14.68M
Inst Own11.5%
SI24.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$19.36M
Total Assets$6.18M
Free Cash Flow-$9.91M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$353K
Shares Outstanding
Short Interest
Split History1 split
- 2:1Forward splitOct 16, 20141 share → 2
Balance Sheet Details
Assets$6.18M
Liabilities$5.82M
Accounts Receivable$0
Accounts Payable$4.87M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $2K | $4K | $4K | $4K | $4K | $4K | $4K | $4K | $4K |
| Gross Profit | -$2K | -$4K | -$4K | -$4K | -$4K | -$4K | -$4K | -$4K | -$4K |
| Gross Margin | - | - | - | - | - | - | - | - | - |
| Research and Development | $17.22M | $15.48M | $7.7M | $6.48M | $3.56M | $1.06M | $2.61M | $1.27M | $1.22M |
| Selling, General, and Administrative | $2.23M | $2.15M | $1.63M | $1.56M | $1.04M | $806K | $819K | $420K | $347K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $19.45M | $17.63M | $9.32M | $8.04M | $4.59M | $1.86M | $3.42M | $1.69M | $1.57M |
| Operating Income (EBIT) | -$19.45M | -$17.64M | -$9.33M | -$8.04M | -$4.6M | -$1.86M | -$3.43M | -$1.69M | -$1.57M |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $90K | $223K | $436K | $215K | $27K | $832 | $0 | $0 | $0 |
| Other Income (Expense) | $90K | $223K | $436K | $215K | $27K | $832 | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$19.36M | -$17.41M | -$8.89M | -$7.83M | -$4.57M | -$1.86M | -$3.43M | -$1.69M | -$1.57M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3 |
| Net Income | -$19.36M | -$17.41M | -$8.89M | -$7.83M | -$4.57M | -$1.86M | -$3.43M | -$1.69M | -$1.57M |
| Net Income Margin | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||
| EPS | -1.43 | -1.21 | -0.69 | -0.61 | -0.35 | -0.15 | -0.29 | -0.14 | -0.13 |
| Diluted EPS | -1.43 | -1.21 | -0.69 | -0.61 | -0.35 | -0.15 | -0.29 | -0.14 | -0.13 |
| Weighted Average OS | 13.53M | 13.01M | 12.85M | 12.91M | 12.94M | 12.70M | 11.74M | 11.97M | 11.74M |
| EBITDA | -$19.36M | -$17.41M | -$8.89M | -$7.82M | -$4.57M | -$1.86M | -$3.42M | -$1.69M | -$1.57M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $6.18M | $4.09M | $6.99M | $13.47M | $27.2M | $28.66M | $7K | $85K | $54 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $6.18M | $4.09M | $6.99M | $13.47M | $27.2M | $28.66M | $7K | $85K | $54 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $6.18M | $4.09M | $6.99M | $13.47M | $27.2M | $28.66M | $7K | $85K | $54 |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $2K | $5K | $9K | $13K | $16K | $20K | $23K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | -$0 | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $2K | $5K | $9K | $13K | $16K | $20K | $23K | $27K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $6.18M | $4.09M | $6.99M | $13.48M | $27.22M | $28.68M | $27K | $109K | $27K |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $4.87M | $2.8M | $35K | $221K | $221K | $711K | $730K | $278K | $161K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $275K | $635K | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $674K | $306K | $0 | $0 | $0 | $0 | -$0 | $451K | $396K |
| Total Current Liabilities | $5.82M | $3.19M | $294K | $263K | $385K | $1.05M | $1.38M | $729K | $558K |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | -$0 | $0 | $9.5M | $8K |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | -$0 | $0 | $9.5M | $8K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $5.82M | $3.19M | $294K | $263K | $385K | $1.05M | $1.38M | $10.23M | $8.56M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $2K | $5K | $5K |
| Common Stock | $14K | $13K | $13K | $13K | $13K | $13K | $8K | $542 | $542 |
| Retained Earnings | -$87.14M | -$67.78M | -$50.36M | -$41.47M | -$33.65M | -$29.08M | -$27.21M | -$23.79M | -$22.1M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | -$0 | -$0 | $0 | $0 | -$541 |
| Other Stockholders' Equity | $87.48M | $68.67M | $57.05M | $54.67M | $60.47M | $56.7M | $25.86M | $13.67M | $13.57M |
| Total Equity | $353K | $909K | $6.7M | $13.21M | $26.83M | $27.63M | -$1.35M | -$10.12M | -$8.53M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $6.18M | $4.09M | $6.99M | $13.48M | $27.22M | $28.68M | $27K | $109K | $27K |
| Supplementary Data | |||||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $275K | $635K | $0 | $0 |
| Net Debt | -$6.18M | -$4.09M | -$6.99M | -$13.47M | -$27.2M | -$28.39M | $628K | -$85K | -$54 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$19.36M | -$15.79M | -$8.89M | -$7.83M | -$4.57M | -$1.86M | -$3.43M | -$1.69M | -$1.57M |
| Depreciation & Amortization | $2K | $4K | $4K | $4K | $4K | $4K | $4K | $4K | $4K |
| Deferred Income Tax | $0 | $0 | $0 | -$1.75M | -$1.19M | -$778K | $0 | $0 | $0 |
| Stock-Based Compensation | $6.8M | $7.25M | $2.38M | $1.74M | $661K | $678K | $195K | $0 | $0 |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $2.07M | $921K | $35K | $0 | -$527K | -$93K | $393K | $81K | $145K |
| Other Working Capital | $568K | $344K | -$4K | -$122K | $142K | $121K | $2.54M | $1.49M | $1.3M |
| Total Working Capital Change | $2.64M | $1.27M | $32K | -$122K | -$385K | $28K | $2.93M | $1.57M | $1.45M |
| Other Non-Cash Items | $0 | $0 | $0 | $1.75M | $1.19M | $778K | $0 | -$74K | -$138K |
| Net Cash from Operating | -$9.91M | -$7.27M | -$6.48M | -$6.2M | -$4.29M | -$1.15M | -$293K | -$115K | -$121K |
| Investing Activities | |||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | |||||||||
| Debt Repaid | - | - | - | - | - | $360K | - | - | - |
| Common Stock Issuance | $12M | $4.37M | $0 | $0 | $3.11M | $30.17M | $0 | $100K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | -$7.54M | $0 | $0 | $0 | $0 | -$90K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | -$275K | $0 | $215K | $100K | -$130K |
| Net Cash from Financing | $12M | $4.37M | $0 | -$7.54M | $2.84M | $29.81M | $215K | $200K | -$130K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.09M | -$2.9M | -$6.48M | -$13.74M | -$1.46M | $28.65M | -$78K | $85K | -$251K |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$9.91M | -$7.27M | -$6.48M | -$6.2M | -$4.29M | -$1.15M | -$293K | -$115K | -$121K |
| Capital Expenditure | $3 | $3 | $0 | -$3 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$9.91M | -$7.27M | -$6.48M | -$6.2M | -$4.29M | -$1.15M | -$293K | -$115K | -$121K |
| Cash at Beginning | $4.09M | $6.99M | $13.47M | $27.2M | $28.66M | $7K | $85K | $54 | $251K |
| Cash at End | $6.18M | $4.09M | $6.99M | $13.47M | $27.2M | $28.66M | $7K | $85K | $54 |